Full-Time

Scientist – Functional Genomics

Posted on 9/12/2024

Calico Labs

Calico Labs

201-500 employees

Research and develop treatments for aging

Biotechnology
Healthcare

Compensation Overview

$127k - $135kAnnually

+ Annual Cash Bonuses

Mid, Senior

San Bruno, CA, USA

Must work onsite five days per week.

Category
Bioinformatics
Genomics
Biology & Biotech
Required Skills
Python
Data Science
R
Requirements
  • Ph.D. in Genomics, Genetics, Molecular Biology, Systems Biology, or a closely related field
  • Strong record of originality and productivity as evidenced by impactful publications
  • Proficient in bulk and single cell *seq technologies (e.g. RNA, ATAC, ChIP, Ribo, CITE)
  • Experienced in large-scale genomic perturbation screens (CRISPR-Cas9, shRNA, etc.)
  • Strong bioinformatics skills with experience analyzing genomic data using R and/or Python
  • Must be willing to work onsite five days per week
Responsibilities
  • Design and apply functional genomics assays to read out interpretable phenotypes underlying the complexities of aging and age-related diseases
  • Execute large-scale perturbation screens and generate multimodal genomics datasets
  • Collaborate with a cross-functional team that includes Research, Discovery Technologies, Data Science, and Machine Learning
  • Utilize novel technologies to answer a complex and diverse set of biological questions

Calico Labs focuses on researching the biology of aging and creating treatments for diseases related to aging. The company uses advanced technologies to explore how aging works and what can be done to combat age-related illnesses. By collaborating with academic institutions and other biopharmaceutical companies, Calico Labs enhances its research efforts and aims to turn scientific findings into real medical solutions. This partnership model allows for shared knowledge and resources, which can lead to faster and more effective breakthroughs in aging research. The company earns revenue through these collaborations, research grants, and potential licensing of its discoveries. Ultimately, Calico Labs seeks to significantly advance the understanding of aging and improve health outcomes for older individuals.

Company Stage

Seed

Total Funding

$2M

Headquarters

South San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

1%

1 year growth

1%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Calico's inclusion in the FDA START program boosts its rare disease drug development.
  • The extended partnership with Broad Institute strengthens Calico's neurodegeneration research.
  • AI-driven drug discovery trends could accelerate Calico's research processes.

What critics are saying

  • Over-reliance on AbbVie partnership could pose risks if strategic misalignments occur.
  • Intensifying competition in the anti-aging sector may overshadow Calico's advancements.
  • Focus on rare diseases may limit market size and revenue potential.

What makes Calico Labs unique

  • Calico Labs focuses on aging and age-related diseases, a niche in biopharmaceuticals.
  • The company leverages strategic partnerships to accelerate research and development.
  • Calico's collaboration with AbbVie enhances its capabilities in rare disease therapeutics.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE